By 2050, over half of the adults and one third of the youth may be obese. Experts have called for urgent action to prevent ...

Both semaglutide and tirzepatide would need big price cuts to be seen as a good buy for the US healthcare system.

They’re expensive and aren’t a short-term fix, but Ozempic and Wegovy show great promise in regulating weight. | Opinion ...

In 2023, the United States marked a major milestone in the battle against a longstanding public health crisis: adult obesity rates dropped for the first time in a decade. Researchers pointed to GLP-1s ...

According to the country’s health commission, roughly a third of China’s residents are overweight, with 16% considered obese.

Researchers at the Advanced Research Unit on Metabolism, Development & Aging (ARUMDA), in the Tata Institute of Fundamental ...

Opinion: In this op-ed, the author argues the Army’s outdated body composition policies are quietly eroding the readiness, ...

In November 2024, Zealand Pharma presented detailed results from the Phase 1b 16-week multiple ascending dose (MAD) trial at ...

March is Colon Cancer Awareness Month. Colon cancer is the second leading cause of cancer deaths in the United States. "We ...